Technical Analysis for EDIT - Editas Medicine, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 2.41 | -2.82% | -0.07 |
EDIT closed down 2.82 percent on Wednesday, November 20, 2024, on 1.31 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% |
Alert | Time |
---|---|
Down 5% | about 18 hours ago |
Possible NR7 | about 18 hours ago |
60 Minute Opening Range Breakdown | about 18 hours ago |
1.5x Volume Pace | about 22 hours ago |
Down 3% | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2024
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome CRISPR DNA Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome CRISPR DNA Genome Editing Cas9
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.69 |
52 Week Low | 2.35 |
Average Volume | 2,151,112 |
200-Day Moving Average | 5.24 |
50-Day Moving Average | 3.26 |
20-Day Moving Average | 2.97 |
10-Day Moving Average | 2.85 |
Average True Range | 0.21 |
RSI (14) | 31.03 |
ADX | 17.13 |
+DI | 15.49 |
-DI | 33.93 |
Chandelier Exit (Long, 3 ATRs) | 3.11 |
Chandelier Exit (Short, 3 ATRs) | 2.99 |
Upper Bollinger Bands | 3.49 |
Lower Bollinger Band | 2.44 |
Percent B (%b) | -0.02 |
BandWidth | 35.73 |
MACD Line | -0.20 |
MACD Signal Line | -0.14 |
MACD Histogram | -0.0608 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.60 | ||||
Resistance 3 (R3) | 2.60 | 2.54 | 2.57 | ||
Resistance 2 (R2) | 2.54 | 2.49 | 2.54 | 2.56 | |
Resistance 1 (R1) | 2.47 | 2.46 | 2.44 | 2.47 | 2.55 |
Pivot Point | 2.41 | 2.41 | 2.40 | 2.41 | 2.41 |
Support 1 (S1) | 2.35 | 2.36 | 2.32 | 2.35 | 2.27 |
Support 2 (S2) | 2.29 | 2.33 | 2.29 | 2.26 | |
Support 3 (S3) | 2.22 | 2.29 | 2.25 | ||
Support 4 (S4) | 2.22 |